The Complement Inhibitor CD59 Regulates Insulin Secretion by Modulating Exocytotic Events

• CD59 is highly expressed and partly localized intracellularly in pancreatic β cells
• CD59 is required for glucose- and depolarization-evoked insulin secretion
• CD59 enables regulated interactions between exocytotic fusion proteins
• CD59 expression is affected by glucose and diabetes status

SummaryType 2 diabetes is triggered by reduced insulin production, caused by genetic and environmental factors such as inflammation originating from the innate immune system. Complement proteins are a component of innate immunity and kill non-self cells by perforating the plasma membrane, a reaction prevented by CD59. Human pancreatic islets express CD59 at very high levels. CD59 is primarily known as a plasma membrane protein in membrane rafts, but most CD59 protein in pancreatic β cells is intracellular. Removing extracellular CD59 disrupts membrane rafts and moderately stimulates insulin secretion, whereas silencing intracellular CD59 markedly suppresses regulated secretion by exocytosis, as demonstrated by TIRF imaging. CD59 interacts with the exocytotic proteins VAMP2 and Syntaxin-1. CD59 expression is reduced by glucose and in rodent diabetes models but upregulated in human diabetic islets, potentially reflecting compensatory reactions. This unconventional action of CD59 broadens the established view of innate immunity in type 2 diabetes.

Graphical AbstractFigure optionsDownload high-quality image (186 K)Download as PowerPoint slide